Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

AI-driven clinical trial recruitment gets another test through AstraZeneca, Oracle deal

20 October 2026 · By · Wire by Fusion42

Published

20 October 2026

Topic

opportunities

◆ Sectors

Digital Health

◆ Geography

United States

◆ Source

Read at emarketer.com →

◆ Verified

Fusion42 · 20 October 2026 · Fusion42 review

AstraZeneca and Oracle have partnered to test AI-driven clinical trial recruitment, aiming to enhance patient enrolment efficiency and trial speed in healthcare research.

This Wire brief sits within Fusion42's coverage of Digital Health, and 5 sources have reported it.

◆ ◆ The Wire takeaway

You can now use AI to cut patient recruitment times for clinical trials, opening faster paths to trial start and patient reach. This deal signals a new normal where healthcare trials depend on smarter data tools from tech giants like Oracle.

◆ Coverage

5 sources · 20 Oct 2026

◆ Related on Wire

◆ Topics

Digital Healthaiclinical-trialshealthtechpartnershippatient-recruitment